Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01023997
Other study ID # A3502
Secondary ID
Status Completed
Phase N/A
First received December 1, 2009
Last updated May 9, 2014
Start date January 2008
Est. completion date January 2013

Study information

Verified date May 2014
Source Aristotle University Of Thessaloniki
Contact n/a
Is FDA regulated No
Health authority Greece: National Organization of Medicines
Study type Observational

Clinical Trial Summary

The purpose of this study is to compare the central corneal thickness measurement in patients with exfoliation syndrome, exfoliative glaucoma, primary open-angle glaucoma, ocular hypertension and normal controls and to evaluate the value of corneal thickness in the diagnosis and management of glaucoma.


Description:

To compare the central corneal thickness measurement in patients with exfoliation, primary open-angle glaucoma, ocular hypertension and normal controls and to evaluate the value of corneal thickness in the diagnosis and management of glaucoma. Prospective study in progress. Randomly selected patients undergo a comprehensive ophthalmic exam which includes 2 separate pachymetry measurements in 2 different examinations at the same time of the day (10:00 am) with 3 different pachymeters. The values obtained are correlated with a number of other glaucoma parameters. A thinner cornea may represent a specific attribute and an additional risk factor for patients with exfoliation. Evaluation of corneal thickness is an important exam in the management of patients with exfoliation.


Recruitment information / eligibility

Status Completed
Enrollment 700
Est. completion date January 2013
Est. primary completion date January 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 25 Years to 89 Years
Eligibility Inclusion Criteria:

- Exfoliation material on pupil

- Intraocular pressure below 21 mm Hg without glaucomatous damage

- Intraocular pressure above 21 mm Hg without glaucomatous damage

- Raised intraocular pressure with glaucomatous damage

Exclusion Criteria:

- Corneal disorders

- History of trauma

- Evidence of corneal abnormality that may influence IOP

- Contact lens use

- Corneal surgery

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Greece Glaucoma Unit, 1st University Department of Ophthalmology Thessaloniki

Sponsors (1)

Lead Sponsor Collaborator
Aristotle University Of Thessaloniki

Country where clinical trial is conducted

Greece, 

Outcome

Type Measure Description Time frame Safety issue
Primary central corneal thickness Morning measurement (10:00-11:00) No
Secondary Visual field, scanning laser polarimetry 10:00-11:00 No
See also
  Status Clinical Trial Phase
Completed NCT01936389 - A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma Phase 2
Completed NCT01022281 - Early Diagnosis in Glaucoma With GDxVcc N/A
Completed NCT01126203 - Randomized Prospective Study of Selective Laser Trabeculoplasty (SLT) Versus Argon Trabeculoplasty (ALT) in Patients With Pseudoexfoliation Glaucoma and Ocular Hypertension Phase 3
Completed NCT00273442 - Assessing Cosopt Switch Patients Phase 4
Completed NCT00331240 - 24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination Phase 3
Terminated NCT02042703 - Imaging Lens Deposits in Exfoliation Syndrome N/A
Unknown status NCT00804115 - The International Collaborative Exfoliation Syndrome Treatment Study N/A